HealthQuill Articles by: HealthQuill
Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.
Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%

Read More
Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the country to make new active pharmaceutical ingredients.
Drugs Health Pharma

Novo Nordisk to invest $2.3 billion to expand Danish facility 

HQ Team June 13, 2023: Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the

Read More
Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental trials of two drugs to treat chronic kidney diseases.
Drugs Health Pharma

Novartis to acquire Chinook Therapeutics in a $3.5 billion deal

HQ Team June 13, 2023: Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental

Read More
A public inquiry starts today in Britain, into the nation’s handling of the Covid-19 pandemic, which killed 224,546 people in the country.
Drugs Health Pharma

Britain’s public inquiry into Covid-19 pandemic to start today

HQ Team June 13, 2023: A public inquiry starts today in Britain, into the nation’s handling of the Covid-19 pandemic, which killed 224,546

Read More
A blood protein, called fibrin, which supports clotting, is responsible for switching on detrimental genes in Alzheimer’s disease and multiple sclerosis, researchers say.
Drugs Health Pharma

Alzheimer’s develops when hero microglia turns into a villain in brain

HQ Team June 11, 2023: A blood protein, called fibrin, which supports clotting, is responsible for switching on detrimental genes in Alzheimer’s disease

Read More
STIs
Drugs Health Medical

Doxycycline demonstrates potential in preventing STIs among high-risk individuals

HQ Team June 10, 2023: A study, funded by the National Institute of Allergy and Infectious Diseases (NIAID), found that using the oral

Read More
gene editing
Drugs Health Medical Pharma

FDA considering approval for first ever CRISPR gene editing technology drug

HQ Team June 10, 2023:The Food and Drug Administration (FDA) has accepted an application for what could become the first-ever marketed medicine based

Read More
An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug nirsevimab, meant to treat lower respiratory tract disease in newborns, according to a statement from the Paris-based firm.
Drugs Health Pharma

FDA’s advisory panel backs Sanofi, AstraZeneca’s investigational drug for newborns

HQ Team June 9, 2023: An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug

Read More
covid-19
Drugs Health Medical

Diabetes medicine metformin cuts risk of developing long Covid by 40%

HQ Team June 9, 2023: Metformin, a cheap and widely-used diabetes drug, reduces the incidence of long Covid by nearly 40 per cent

Read More
AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to develop cell therapies for treating autoimmune diseases.
Drugs Health Pharma

AstraZeneca signs $2 billion deal for autoimmune diseases

HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to

Read More